Search

Search Constraints

You searched for: Author/Creator Sanders, Joyce

Search Results

1. Assessment of PD-L1 expression across breast cancer molecular subtypes, in relation to mutation rate, BRCA1-like status, tumor-infiltrating immune cells and survival. (2nd December 2018)

2. Molecular characterization of colorectal adenomas reveals POFUT1 as a candidate driver of tumor progression. Issue 7 (30th August 2019)

3. Epithelial-to-mesenchymal transition is a prognostic marker for patient outcome in advanced stage HNSCC patients treated with chemoradiotherapy. (June 2020)

5. Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS. (November 2019)

6. SERPINB9 is commonly amplified and high expression in cancer cells correlates with poor immune checkpoint blockade response. (31st December 2022)

7. Tumour-infiltrating lymphocytes (TILs) and BRCA-like status in stage III breast cancer patients randomised to adjuvant intensified platinum-based chemotherapy versus conventional chemotherapy. (March 2020)

9. In vivo tumor identification of colorectal liver metastases with diffuse reflectance and fluorescence spectroscopy. Issue 9 (8th September 2016)

10. Quantitative analysis of CDX2 protein expression improves its clinical utility as a prognostic biomarker in stage II and III colon cancer. (February 2021)